학술논문

Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
Document Type
Journal Article
Source
BMC Cancer. 2/6/2019, Vol. 19 Issue 1, p1-13. 13p. 1 Diagram, 8 Charts, 2 Graphs.
Subject
*META-analysis
*CANCER patients
*TUMOR markers
*COLORECTAL cancer
*PROGRESSION-free survival
Language
ISSN
1471-2407
Abstract
Background: The prognostic value of Ki-67 expression in colorectal cancer patients was controversial. Therefore, this meta analysis was conducted to ascertain the prognostic value of Ki-67 expression in colorectal cancer patients.Methods: The electronic databases, including EMBASE, PubMed, Cochrane Library and Web of Knowledge database, were searched from January 1970 to July 2017. The pooled hazard ratios and 95% confidence intervals were calculated to evaluate the prognostic value of Ki-67 expression for colorectal cancer patients.Results: Totally 34 eligible studies and 6180 colorectal cancer patients were included in the present meta analysis. The pooled hazard ratios were 1.54(95% CI 1.17-2.02, P = 0.005) for overall survival and 1.43(1.12-1.83, P = 0.008) for disease free survival in univariate analysis. After adjustment of other prognostic factors, the pooled HR was 1.50(95% CI 1.02-2.22, P = 0.03) for overall survival in multivariate analysis.Conclusion: The present meta analysis demonstrated that high Ki-67 expression is significantly correlated with poor overall survival and disease free survival, indicating that high Ki-67 expression may serve as a valuable predictive method for poor prognosis of colorectal cancer patients. [ABSTRACT FROM AUTHOR]